Healthy adults
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Healthy Japanese adults 2. BMI (25 kg/m2 to less than 30 kg/m2)
Exclusion criteria
Exclusion criteria: 1. At least one previous medical history of malignant tumor, heart failure or myocardial infarction 2. Currently under the treatment for either atrial fibrillation, cardiac arrhythmia, hepatic disorder, renal disorder, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension or other chronic diseases 3. Currently taking medicines (include herbal medicines), and/or supplements 4. Allergic to medicines or foods related to the test food of this trial 5. Pregnant, lactating, or planning to get pregnant during the trial period 6. Enrolled into other clinical trials within the last 3 months before agreeing to participate in this trial 7. Judged unsuitable for participating in this trial by physician
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Total fat area 2. Subcutaneous fat area 3. Visceral fat area *Measuring point: at 0 week, 4 weeks, 8 weeks and 12 weeks after ingestion | — |
Secondary
| Measure | Time frame |
|---|---|
| Weight Body Mass Index (BMI) Body fat percentage Waist Circumference Adiponectin Total cholesterol HDL cholesterol LDL cholesterol Triglyceride Free fatty acid Questionnaire (Likert scale) *Measuring point: at 0 week, 4 weeks, 8 weeks and 12 weeks after ingestion | — |
Countries
Japan
Contacts
ORTHOMEDICO, Inc. R&D Department